Literature DB >> 25947146

Protection Provided by an Encapsulated Live Attenuated ΔabcBA Strain of Brucella ovis against Experimental Challenge in a Murine Model.

Ana Patrícia C Silva1, Auricélio A Macêdo1, Teane M A Silva2, Luana C A Ximenes2, Humberto M Brandão3, Tatiane A Paixão2, Renato L Santos4.   

Abstract

This study aimed to evaluate the Brucella ovis ΔabcBA strain as a vaccine candidate in the murine model. BALB/c mice were subcutaneously or intraperitoneally immunized with a single dose or three doses of the B. ovis ΔabcBA strain and then were challenged with wild-type B. ovis. Single or multiple immunizations provided only mild protection, with significantly smaller numbers of wild-type B. ovis CFU in the livers of immunized mice but not in the spleens. Encapsulation of B. ovis ΔabcBA significantly improved protection against experimental challenges in both BALB/c and C57BL/6 mice. Furthermore, immunization with encapsulated B. ovis ΔabcBA markedly prevented lesions in the spleens and livers of experimentally challenged mice. These results demonstrated that the encapsulated B. ovis ΔabcBA strain confers protection to mice; therefore, this strain has potential as a vaccine candidate for rams.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25947146      PMCID: PMC4478529          DOI: 10.1128/CVI.00191-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  33 in total

1.  Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro.

Authors:  Hongfan Sun; Kevin G J Pollock; James M Brewer
Journal:  Vaccine       Date:  2003-02-14       Impact factor: 3.641

2.  PLACENTAL PATHOLOGY. I. PLACENTAL LESIONS OF SHEEP EXPERIMENTALLY INFECTED WITH BRUCELLA OVIS.

Authors:  J A MOLELLO; R JENSEN; J C FLINT; J R COLLIER
Journal:  Am J Vet Res       Date:  1963-09       Impact factor: 1.156

3.  Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 4.  Ovine contagious epididymitis: a review.

Authors:  G W Burgess
Journal:  Vet Microbiol       Date:  1982-12       Impact factor: 3.293

Review 5.  A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.

Authors:  J M Blasco
Journal:  Prev Vet Med       Date:  1997-08       Impact factor: 2.670

6.  The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.

Authors:  Cyntia G M C Trant; Thais L S Lacerda; Natalia B Carvalho; Vasco Azevedo; Gracia M S Rosinha; Suzana P Salcedo; Jean-Pierre Gorvel; Sergio C Oliveira
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

7.  Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles.

Authors:  Raquel Da Costa Martins; Carlos Gamazo; María Sánchez-Martínez; Montserrat Barberán; Iván Peñuelas; Juan M Irache
Journal:  J Control Release       Date:  2012-07-28       Impact factor: 9.776

8.  MyD88 and TLR9 are required for early control of Brucella ovis infection in mice.

Authors:  Ana Luiza S Vieira; Teane M A Silva; Juliana P S Mol; Sergio C Oliveira; Renato L Santos; Tatiane A Paixão
Journal:  Res Vet Sci       Date:  2012-12-03       Impact factor: 2.534

9.  A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.

Authors:  Juliana Cassataro; Karina A Pasquevich; Silvia M Estein; Diego A Laplagne; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei; Fernando A Goldbaum
Journal:  Vaccine       Date:  2007-04-02       Impact factor: 3.641

10.  Genome degradation in Brucella ovis corresponds with narrowing of its host range and tissue tropism.

Authors:  Renee M Tsolis; Rekha Seshadri; Renato L Santos; Felix J Sangari; Juan M García Lobo; Maarten F de Jong; Qinghu Ren; Garry Myers; Lauren M Brinkac; William C Nelson; Robert T Deboy; Samuel Angiuoli; Hoda Khouri; George Dimitrov; Jeffrey R Robinson; Stephanie Mulligan; Richard L Walker; Philip E Elzer; Karl A Hassan; Ian T Paulsen
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more
  9 in total

1.  Encapsulated Brucella ovis Lacking a Putative ATP-Binding Cassette Transporter (ΔabcBA) Protects against Wild Type Brucella ovis in Rams.

Authors:  Ana Patrícia C Silva; Auricélio A Macêdo; Luciana F Costa; Cláudia E Rocha; Luize N N Garcia; Jade R D Farias; Priscilla P R Gomes; Gustavo C Teixeira; Kessler W J Fonseca; Andréa R F Maia; Gabriela G Neves; Everton L Romão; Teane M A Silva; Juliana P S Mol; Renata M Oliveira; Márcio S S Araújo; Ernane F Nascimento; Olindo A Martins-Filho; Humberto M Brandão; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

2.  Meta-Analysis and Advancement of Brucellosis Vaccinology.

Authors:  Tatiane F Carvalho; João Paulo A Haddad; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

3.  Evaluation of the Efficacy of the Brucella canis RM6/66 ΔvjbR Vaccine Candidate for Protection against B. canis Infection in Mice.

Authors:  Daniel G Garcia-Gonzalez; Omar H Khalaf; Lauren W Stranahan; Sankar P Chaki; Angela M Arenas-Gamboa
Journal:  mSphere       Date:  2020-05-20       Impact factor: 4.389

4.  A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams.

Authors:  Pilar M Muñoz; Raquel Conde-Álvarez; Sara Andrés-Barranco; María-Jesús de Miguel; Amaia Zúñiga-Ripa; Beatriz Aragón-Aranda; Miriam Salvador-Bescós; Estrella Martínez-Gómez; Maite Iriarte; Montserrat Barberán; Nieves Vizcaíno; Ignacio Moriyón; José M Blasco
Journal:  Vet Res       Date:  2022-03-02       Impact factor: 3.683

5.  Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model.

Authors:  Ayman Al-Mariri; Laila Al-Hallab; Rasha Alabras; Heba Kherbik; Marwa Khawajkiah
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

Review 6.  When the Going Gets Rough: The Significance of Brucella Lipopolysaccharide Phenotype in Host-Pathogen Interactions.

Authors:  Lauren W Stranahan; Angela M Arenas-Gamboa
Journal:  Front Microbiol       Date:  2021-07-15       Impact factor: 5.640

7.  Characterization of Cell Envelope Multiple Mutants of Brucella ovis and Assessment in Mice of Their Vaccine Potential.

Authors:  Rebeca Singh Sidhu-Muñoz; Pilar Sancho; Axel Cloeckaert; Michel Stanislas Zygmunt; María Jesús de Miguel; Carmen Tejedor; Nieves Vizcaíno
Journal:  Front Microbiol       Date:  2018-09-20       Impact factor: 5.640

8.  Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs.

Authors:  Camila Eckstein; Juliana P S Mol; Fabíola B Costa; Philipe P Nunes; Pâmela A Lima; Marília M Melo; Thaynara P Carvalho; Daniel O Santos; Monique F Silva; Tatiane F Carvalho; Luciana F Costa; Otoni A O Melo Júnior; Rodolfo C Giunchette; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

9.  Disruption of pyruvate phosphate dikinase in Brucella ovis PA CO2-dependent and independent strains generates attenuation in the mouse model.

Authors:  Nieves Vizcaíno; Lara Pérez-Etayo; Raquel Conde-Álvarez; Maite Iriarte; Ignacio Moriyón; Amaia Zúñiga-Ripa
Journal:  Vet Res       Date:  2020-08-14       Impact factor: 3.683

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.